Koike R
Department of Pediatrics, Kyorin University School of Medicine, Tokyo, Japan.
Acta Paediatr Jpn. 1991 Jun;33(3):300-9. doi: 10.1111/j.1442-200x.1991.tb01558.x.
In mucocutaneous lymph node syndrome (MCLS) IgG and IgM class immune complex (IC) showed peak levels on day 10 to 20 after the onset of the disease respectively, and a transient decrease in IgM class IC was detected at the beginning of intravenous high dose gamma-globulin therapy (IHDGT). In in vitro examination, when gamma-globulin was added to the serum samples of MCLS patients, IgG class IC increased while IgM class IC decreased. Consumption of complements was also observed in these samples. Disposition of IC in the reticuloendothelial system seemed easier by both binding of gamma-globulin to IC and increasing complement bound to IC resulting in increasing complement-binding site. These results suggest that IHDGT is effective for the treatment of IC in MCLS. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) revealed 14 bands from 300 K.D. to 42 K.D. in IC of MCLS patients in the acute phase of the disease and prior to treatment. The immunoblotting method revealed that IC contains IgG, IgM, IgE, IgA, Clq, C3, and C4.
在皮肤黏膜淋巴结综合征(MCLS)中,IgG和IgM类免疫复合物(IC)分别在疾病发作后第10至20天达到峰值水平,并且在静脉注射大剂量丙种球蛋白疗法(IHDGT)开始时检测到IgM类IC短暂下降。在体外检查中,当向MCLS患者的血清样本中添加丙种球蛋白时,IgG类IC增加而IgM类IC减少。在这些样本中还观察到补体的消耗。通过丙种球蛋白与IC的结合以及增加与IC结合的补体从而增加补体结合位点,免疫复合物在网状内皮系统中的处置似乎更容易。这些结果表明IHDGT对治疗MCLS中的IC有效。十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)显示,在疾病急性期和治疗前,MCLS患者的IC中有14条带,分子量从300 K.D.到42 K.D.。免疫印迹法显示IC含有IgG、IgM、IgE、IgA、Clq、C3和C4。